Genmab A/SNASDAQ:GMAB
- LAST PRICE20.6700
- TODAY'S CHANGE (%)-0.5100 (-2.4079%)
- Bid / Lots20.6600/ 8
- Ask / Lots20.6700/ 8
- Open / Previous Close21.0100 / 21.1800
- Day Range
- 52 Week Range
- Volume618,966
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GMAB |
|---|---|---|
| 09:32 ET | 15155 | 20.91 |
| 09:33 ET | 3100 | 20.91 |
| 09:35 ET | 783 | 20.88 |
| 09:37 ET | 11015 | 20.87 |
| 09:39 ET | 5879 | 20.85 |
| 09:42 ET | 11491 | 20.8012 |
| 09:44 ET | 4600 | 20.79 |
| 09:46 ET | 2000 | 20.78 |
| 09:48 ET | 5186 | 20.745 |
| 09:50 ET | 23243 | 20.74 |
| 09:51 ET | 9923 | 20.76 |
| 09:53 ET | 6142 | 20.8 |
| 09:55 ET | 2245 | 20.8 |
| 09:57 ET | 2100 | 20.79 |
| 10:00 ET | 3588 | 20.8 |
| 10:02 ET | 4496 | 20.79 |
| 10:04 ET | 2239 | 20.8 |
| 10:06 ET | 2298 | 20.815 |
| 10:08 ET | 3115 | 20.82 |
| 10:09 ET | 5000 | 20.77 |
| 10:11 ET | 6666 | 20.775 |
| 10:13 ET | 10526 | 20.72 |
| 10:15 ET | 5133 | 20.725 |
| 10:18 ET | 2517 | 20.745 |
| 10:20 ET | 5736 | 20.745 |
| 10:22 ET | 1010 | 20.725 |
| 10:24 ET | 2212 | 20.7 |
| 10:26 ET | 5022 | 20.71 |
| 10:27 ET | 4511 | 20.69 |
| 10:29 ET | 2942 | 20.7 |
| 10:31 ET | 5949 | 20.68 |
| 10:33 ET | 5983 | 20.655 |
| 10:36 ET | 5727 | 20.64 |
| 10:38 ET | 1100 | 20.615 |
| 10:40 ET | 883 | 20.629 |
| 10:42 ET | 789 | 20.63 |
| 10:44 ET | 232 | 20.61 |
| 10:45 ET | 519 | 20.59 |
| 10:47 ET | 3009 | 20.6 |
| 10:49 ET | 4943 | 20.63 |
| 10:51 ET | 5029 | 20.635 |
| 10:54 ET | 4451 | 20.6 |
| 10:56 ET | 1968 | 20.585 |
| 10:58 ET | 1300 | 20.545 |
| 11:00 ET | 4314 | 20.54 |
| 11:02 ET | 1477 | 20.53 |
| 11:03 ET | 2861 | 20.53 |
| 11:05 ET | 10578 | 20.515 |
| 11:07 ET | 460 | 20.51 |
| 11:09 ET | 21559 | 20.535 |
| 11:12 ET | 34318 | 20.545 |
| 11:14 ET | 45968 | 20.55 |
| 11:16 ET | 4165 | 20.62 |
| 11:18 ET | 3204 | 20.615 |
| 11:20 ET | 1298 | 20.615 |
| 11:21 ET | 1049 | 20.61 |
| 11:23 ET | 2851 | 20.635 |
| 11:25 ET | 2607 | 20.645 |
| 11:27 ET | 2237 | 20.625 |
| 11:30 ET | 1011 | 20.62 |
| 11:32 ET | 628 | 20.615 |
| 11:34 ET | 511 | 20.605 |
| 11:36 ET | 847 | 20.615 |
| 11:38 ET | 800 | 20.61 |
| 11:39 ET | 10013 | 20.605 |
| 11:41 ET | 1300 | 20.6 |
| 11:43 ET | 200 | 20.595 |
| 11:45 ET | 1753 | 20.615 |
| 11:48 ET | 2705 | 20.615 |
| 11:50 ET | 2500 | 20.635 |
| 11:52 ET | 2001 | 20.615 |
| 11:54 ET | 8886 | 20.625 |
| 11:56 ET | 6523 | 20.645 |
| 11:57 ET | 3153 | 20.64 |
| 11:59 ET | 5511 | 20.645 |
| 12:01 ET | 1548 | 20.66 |
| 12:03 ET | 1604 | 20.645 |
| 12:06 ET | 3878 | 20.655 |
| 12:08 ET | 3980 | 20.65 |
| 12:10 ET | 997 | 20.655 |
| 12:12 ET | 2261 | 20.645 |
| 12:14 ET | 300 | 20.645 |
| 12:15 ET | 1100 | 20.645 |
| 12:17 ET | 2215 | 20.6432 |
| 12:19 ET | 1300 | 20.645 |
| 12:21 ET | 1500 | 20.645 |
| 12:24 ET | 3300 | 20.645 |
| 12:26 ET | 3600 | 20.6292 |
| 12:28 ET | 3022 | 20.635 |
| 12:30 ET | 2086 | 20.635 |
| 12:32 ET | 1361 | 20.625 |
| 12:33 ET | 3656 | 20.635 |
| 12:35 ET | 1500 | 20.625 |
| 12:37 ET | 15511 | 20.635 |
| 12:39 ET | 1002 | 20.645 |
| 12:42 ET | 1165 | 20.65 |
| 12:44 ET | 11762 | 20.655 |
| 12:46 ET | 9089 | 20.675 |
| 12:48 ET | 2601 | 20.675 |
| 12:50 ET | 3394 | 20.665 |
| 12:51 ET | 200 | 20.665 |
| 12:53 ET | 1390 | 20.665 |
| 12:55 ET | 2680 | 20.675 |
| 12:57 ET | 2999 | 20.665 |
Today
DJ Genmab A/S Stock Falls Friday, Underperforms Market, from 1 hour ago by Dow Jones
1 hour ago by Dow Jones
Yesterday
DJ Genmab A/S Stock Falls Thursday, Underperforms Market, from 12:02PM ET on Thursday Nov 14, 2024 by Dow Jones
12:02PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
DJ Genmab A/S Stock Falls Wednesday, Underperforms Market, from 12:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
12:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
DJ Genmab A/S Stock Falls Tuesday, Outperforms Market, from 12:02PM ET on Tuesday Nov 12, 2024 by Dow Jones
12:02PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 11, 2024
DJ Genmab A/S Stock Rises Monday, Underperforms Market, from 12:02PM ET on Monday Nov 11, 2024 by Dow Jones
12:02PM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Genmab A/S | 14.2B | 20.5x | +22.71% |
Galapagos NV | 1.8B | -28.2x | --- |
Beam Therapeutics Inc | 2.2B | -14.1x | --- |
BioCryst Pharmaceuticals Inc | 1.5B | -11.6x | --- |
MiMedx Group Inc | 1.4B | 18.9x | --- |
Twist Bioscience Corp | 2.3B | -9.7x | --- |
Company Information
Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.
Contact Information
- Headquarters
- Carl Jacobsens Vej 30VALBY, Denmark 2500
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Deirdre Connelly
- President, Chief Executive Officer
- Jan Van De Winkel
- Independent Deputy Chairman of the Board
- Pernille Erenbjerg
- Chief Financial Officer, Executive Vice President
- Anthony Pagano
- Executive Vice President, Chief People Officer
- Christopher Cozic
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.2B |
|---|---|
Revenue (TTM) | $2.8B |
Shares Outstanding | 661.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.97 |
EPS | $1.01 |
Book Value | $6.83 |
P/E Ratio | 20.5x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | 33.9x |
Operating Margin | 31.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
